年度十大发现:神经瘤学
1Department of Pathology, Amsterdam University Medical Centers, location VUmc, Brain Tumor Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.
Free neuropathology
|June 7, 2023
概括
神经瘤病理学在中枢神经系统瘤诊断和分类方面在2019年取得了重大进展. 虽然对脑髓母细胞瘤和质瘤的了解越来越多,但改善患者的治疗结果仍然是一个挑战.
科学领域:
- 神经科学是一个神经科学.
- 神经瘤学神经瘤学
- 病理学 病理学 病理学
背景情况:
- 2019年在神经瘤病理学方面取得了重大进展.
- 进展包括诊断,分类,病理生物学和中枢神经系统 (CNS) 瘤的治疗策略.
研究的目的:
- 从2019年开始,回顾神经瘤病理学的前十大发现.
- 突出了解中枢神经系统瘤的进展,包括脑髓母细胞瘤和扩散性质瘤.
主要方法:
- 从2019年开始,对10个选定的关键出版物的审查.
- 讨论新的免疫组织化学和分子标记物.
- 对病理生物学方面的分析和对分类的改进.
主要成果:
- 改善了中枢神经系统瘤的诊断标记和精细分类,特别是脑髓母细胞瘤.
- 阐明脑髓母细胞瘤组织生成和分子进化.
- 洞察质瘤透,癌症干细胞和分子进化.
结论:
- 2019年在理解神经瘤病理学方面取得了重大进展.
- 新发现引发了进一步的研究问题.
- 将这些见解转化为改善中枢神经系统瘤患者的治疗结果是一个持续的挑战.
相关概念视频
Neurogenesis and Regeneration of Nervous Tissue
886
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
886
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


